Tuesday, September 25, 2012

Investigators say no proof unapproved drugs from McLeod were effective U.S. Attorney's office says with unapproved drugs "you don't know what you get"


» 0 Comments | Post a Comment
It's described as a scheme by top management at Mcleod Cancer and Blood Center to get foreign unapproved cancer drugs cheap, mingle them with FDA- approved ones and then hide the evidence from concerned nurses- ultimately giving the drugs to patients.
Tonight we have new information about the investigation.
McLeod’s former business manager Michael Dean Combs laid it all out last week. Combs pleaded guilty to receiving misbranded drugs in violation of the Food, Drug and Cosmetic Act.
It’s the result of a federal investigation centered around unapproved cancer drugs at clinics across the country.
We have team coverage tonight on the investigation, the future of the case and the potential impact on patients.
Combs is the first and only person to be charged locally so far.
Assistant U.S. Attorney Neil Smith wouldn't name any names, but did tell us "additional charges are anticipated."
To read the remainder of the article and see the video click here.

No comments: